キャンバスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/01/23 | 1,352 | 1,356 | 1,255 | 1,262 | -89 | -6.6% | 2,358,300 |
| 2023/01/20 | 1,220 | 1,370 | 1,219 | 1,351 | +115 | +9.3% | 2,697,600 |
| 2023/01/19 | 1,229 | 1,255 | 1,205 | 1,236 | -4 | -0.3% | 822,000 |
| 2023/01/18 | 1,246 | 1,287 | 1,220 | 1,240 | -20 | -1.6% | 1,255,100 |
| 2023/01/17 | 1,216 | 1,262 | 1,216 | 1,260 | +35 | +2.9% | 823,000 |
| 2023/01/16 | 1,214 | 1,246 | 1,193 | 1,225 | -5 | -0.4% | 913,400 |
| 2023/01/13 | 1,310 | 1,322 | 1,222 | 1,230 | -88 | -6.7% | 1,368,000 |
| 2023/01/12 | 1,360 | 1,360 | 1,292 | 1,318 | -36 | -2.7% | 1,004,600 |
| 2023/01/11 | 1,301 | 1,368 | 1,296 | 1,354 | +44 | +3.4% | 1,888,400 |
| 2023/01/10 | 1,225 | 1,325 | 1,209 | 1,310 | +85 | +6.9% | 1,585,300 |
| 2023/01/06 | 1,249 | 1,284 | 1,202 | 1,225 | -32 | -2.5% | 1,672,300 |
| 2023/01/05 | 1,157 | 1,260 | 1,156 | 1,257 | +83 | +7.1% | 2,132,000 |
| 2023/01/04 | 1,140 | 1,194 | 1,121 | 1,174 | +6 | +0.5% | 1,511,700 |
| 2022/12/30 | 1,160 | 1,230 | 1,114 | 1,168 | +28 | +2.5% | 2,477,400 |
| 2022/12/29 | 1,202 | 1,223 | 1,125 | 1,140 | -46 | -3.9% | 2,096,100 |
| 2022/12/28 | 1,170 | 1,263 | 1,143 | 1,186 | +22 | +1.9% | 2,919,000 |
| 2022/12/27 | 1,186 | 1,240 | 1,143 | 1,164 | -39 | -3.2% | 2,265,800 |
| 2022/12/26 | 1,312 | 1,319 | 1,115 | 1,203 | -151 | -11.2% | 2,958,100 |
| 2022/12/23 | 1,255 | 1,389 | 1,222 | 1,354 | +104 | +8.3% | 4,107,300 |
| 2022/12/22 | 1,320 | 1,333 | 1,224 | 1,250 | -75 | -5.7% | 2,671,900 |
| 2022/12/21 | 1,371 | 1,400 | 1,310 | 1,325 | -34 | -2.5% | 1,407,900 |
| 2022/12/20 | 1,487 | 1,507 | 1,304 | 1,359 | -128 | -8.6% | 3,164,300 |
| 2022/12/19 | 1,550 | 1,599 | 1,467 | 1,487 | -39 | -2.6% | 2,985,600 |
| 2022/12/16 | 1,370 | 1,533 | 1,353 | 1,526 | +126 | +9% | 5,346,900 |
| 2022/12/15 | 1,516 | 1,522 | 1,351 | 1,400 | -94 | -6.3% | 4,031,100 |
| 2022/12/14 | 1,529 | 1,567 | 1,468 | 1,494 | -24 | -1.6% | 4,544,500 |
| 2022/12/13 | 1,379 | 1,518 | 1,371 | 1,518 | +109 | +7.7% | 5,881,500 |
| 2022/12/12 | 1,311 | 1,460 | 1,290 | 1,409 | +104 | +8% | 8,131,200 |
| 2022/12/09 | 1,241 | 1,336 | 1,221 | 1,305 | +59 | +4.7% | 3,833,700 |
| 2022/12/08 | 1,333 | 1,342 | 1,240 | 1,246 | -98 | -7.3% | 3,896,100 |
| 2022/12/07 | 1,226 | 1,345 | 1,204 | 1,344 | +143 | +11.9% | 7,397,600 |
| 2022/12/06 | 1,110 | 1,226 | 1,069 | 1,201 | +67 | +5.9% | 3,257,100 |
| 2022/12/05 | 1,157 | 1,198 | 1,113 | 1,134 | -48 | -4.1% | 2,344,600 |
| 2022/12/02 | 1,150 | 1,258 | 1,136 | 1,182 | +81 | +7.4% | 6,682,100 |
| 2022/12/01 | 1,100 | 1,167 | 1,027 | 1,101 | +35 | +3.3% | 4,754,200 |
| 2022/11/30 | 1,078 | 1,129 | 1,065 | 1,066 | -72 | -6.3% | 3,029,700 |
| 2022/11/29 | 1,185 | 1,243 | 1,042 | 1,138 | +2 | +0.2% | 11,089,800 |
| 2022/11/28 | 1,002 | 1,180 | 1,002 | 1,136 | +136 | +13.6% | 10,594,600 |
| 2022/11/25 | 946 | 1,027 | 930 | 1,000 | +45 | +4.7% | 6,305,500 |
| 2022/11/24 | 817 | 973 | 806 | 955 | +123 | +14.8% | 5,182,900 |
| 2022/11/22 | 740 | 839 | 740 | 832 | +89 | +12% | 3,992,200 |
| 2022/11/21 | 760 | 771 | 740 | 743 | -38 | -4.9% | 1,025,300 |
| 2022/11/18 | 850 | 853 | 781 | 781 | -27 | -3.3% | 3,235,000 |
| 2022/11/17 | 757 | 815 | 749 | 808 | +36 | +4.7% | 1,223,600 |
| 2022/11/16 | 741 | 773 | 737 | 772 | +22 | +2.9% | 536,200 |
| 2022/11/15 | 737 | 758 | 722 | 750 | +6 | +0.8% | 690,900 |
| 2022/11/14 | 727 | 766 | 721 | 744 | +27 | +3.8% | 1,100,200 |
| 2022/11/11 | 724 | 738 | 711 | 717 | -14 | -1.9% | 747,000 |
| 2022/11/10 | 719 | 743 | 708 | 731 | +12 | +1.7% | 744,000 |
| 2022/11/09 | 710 | 729 | 703 | 719 | -2 | -0.3% | 479,400 |
601～
650
件表示中 / 3734件
類似銘柄と比較する
現在ご覧いただいている「ＣＡＮＢＡＳ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＣＡＮＢＡＳ | 102,600円 | - | - | 0.00% | - | 6.77倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| レナサイエンス | 192,100円 | -14.4% | - | 0.00% | - | 14.19倍 |
|
東北大発創薬ベンチャー。創業者の宮田同大教授が発見した低分子化合物を使い治療薬を開発 |
| アンジェス | 6,100円 | +110.0% | - | 0.00% | - | 10.50倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
| 扶桑薬 | 209,500円 | +1.6% | -12.7% | 4.30% | 7.78倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ステムリム | 30,500円 | - | - | 0.00% | - | 2.81倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
市場注目の銘柄
チャート関連のコラム
